Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danny De Sarno

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Scientific Reports|December 5, 2023
CT perfusion stroke lesion threshold calibration between deconvolution algorithmsKevin J Chung, Danny De Sarno, Ting-Yim Lee
Medical Physics|August 9, 2025
Framework to calculate <sup>225</sup>Ac, <sup>177</sup>Lu, and <sup>161</sup>Tb radiation dose and biological effect in metastatic castration-resistant prostate cancer treatmentShahin Ghaseminejad, Danny De Sarno, Glenn Bauman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersDanny De Sarno, Jaspreet Bhangu, Michael J Borrie, et al.
Frontiers in Oncology|August 20, 2025
A proof-of-concept study of personalized dosimetry for targeted radioligand therapy using pre-treatment diagnostic dynamic PET/CT and Monte Carlo simulationThanh Tai Duong, Danny De Sarno, Hatim Fakir, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Scientific Reports|December 5, 2023
CT perfusion stroke lesion threshold calibration between deconvolution algorithmsKevin J Chung, Danny De Sarno, Ting-Yim Lee
Medical Physics|August 9, 2025
Framework to calculate <sup>225</sup>Ac, <sup>177</sup>Lu, and <sup>161</sup>Tb radiation dose and biological effect in metastatic castration-resistant prostate cancer treatmentShahin Ghaseminejad, Danny De Sarno, Glenn Bauman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersDanny De Sarno, Jaspreet Bhangu, Michael J Borrie, et al.
Frontiers in Oncology|August 20, 2025
A proof-of-concept study of personalized dosimetry for targeted radioligand therapy using pre-treatment diagnostic dynamic PET/CT and Monte Carlo simulationThanh Tai Duong, Danny De Sarno, Hatim Fakir, et al.
Pageof 1